PFE | Financial Buzz

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer’s Paxlovid Approval, Tollovir™ Phase 2 & COVID Testing

financial buzz12/23/2021

1171

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Gerald Commissiong, CEO of Todos Medical, is scheduled to appear on Yahoo Finance...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer Receives FDA Approval for its Covid-19 Oral Treatment

Rebecca Urena12/22/2021

218

Pfizer’s (NYSE: PFE) oral Covid treatment, Paxlovid, was granted emergency authorization by the Food and Drug Administration on Wednesday. This is the first approved antiviral Covid-19 pill for infected...

Healthcare Investing News Market News Pharmaceutical Science Technology The Market Buzz

Pfizer Reported Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate

Bryan Shin12/15/202112/15/2021

248

Pfizer Inc. (NYSE: PFE) stock continues to climb as the threat from new variants of COVID 19 endures. PFE shares are up another 3%, currently trading near the all-time...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Biden Administration Secures Millions of Pfizer Covid Treatment Pill Courses

Rebecca Urena11/18/202111/18/2021

2305

President Biden expressed Thursday that the government had acquired 10 million treatment courses of Pfizer’s Covid pill. According to Pfizer (NYSE: PFE), the antiviral pill prevents the hospitalization and...

Healthcare Investing News Market News Technology The Market Buzz

Pfizer said Covid Pill with HIV rug Cuts Risk of Hospitalization or Death by 89%

Andy Liao11/05/2021

3214

Pfizer, Inc. (NYSE: PFE) said on Friday that its Covid-19 Pill that is used in combination with a HIV drug, cuts risk of hospitalization or death by 89% n...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer Covid Booster Shots Receive FDA Approval for People 65 and Older

Rebecca Urena09/23/202109/23/2021

2146

The Food and Drug Administration has granted emergency use authorization to Pfizer (NYSE: PFE) and BioNtech for its Covid-19 booster shots in people 65 years and older as well...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer Reports $7.8 Billion in Covid Vaccines Sales During Q2

Rebecca Urena07/28/202107/28/2021

1729

Pfizer (NYSE: PFE) disclosed better-than expected earnings and revenue Wednesday after having sold USD7.8 Billion in Covid-19 vaccines throughout the second quarter. Due to the continued spread of the...

Tag: PFE

Breaking News: Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer’s Paxlovid Approval, Tollovir™ Phase 2 & COVID Testing

Pfizer Receives FDA Approval for its Covid-19 Oral Treatment

Pfizer Reported Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate

Biden Administration Secures Millions of Pfizer Covid Treatment Pill Courses

Pfizer said Covid Pill with HIV rug Cuts Risk of Hospitalization or Death by 89%

Pfizer Covid Booster Shots Receive FDA Approval for People 65 and Older

Pfizer Reports $7.8 Billion in Covid Vaccines Sales During Q2

ABOUT US

Tweets